206 related articles for article (PubMed ID: 26633538)
1. Mast Cell Proteases 6 and 7 Stimulate Angiogenesis by Inducing Endothelial Cells to Release Angiogenic Factors.
de Souza Junior DA; Borges AC; Santana AC; Oliver C; Jamur MC
PLoS One; 2015; 10(12):e0144081. PubMed ID: 26633538
[TBL] [Abstract][Full Text] [Related]
2. Mast Cell Protease 7 Promotes Angiogenesis by Degradation of Integrin Subunits.
de Souza Junior DA; Santana C; Vieira GV; Oliver C; Jamur MC
Cells; 2019 Apr; 8(4):. PubMed ID: 31013764
[TBL] [Abstract][Full Text] [Related]
3. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
Hamsa TP; Kuttan G
Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
[TBL] [Abstract][Full Text] [Related]
4. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor.
Blair RJ; Meng H; Marchese MJ; Ren S; Schwartz LB; Tonnesen MG; Gruber BL
J Clin Invest; 1997 Jun; 99(11):2691-700. PubMed ID: 9169499
[TBL] [Abstract][Full Text] [Related]
5. Mast Cells Interact with Endothelial Cells to Accelerate In Vitro Angiogenesis.
de Souza Junior DA; Mazucato VM; Santana AC; Oliver C; Jamur MC
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236033
[TBL] [Abstract][Full Text] [Related]
6. The Role of Mast Cell Specific Chymases and Tryptases in Tumor Angiogenesis.
de Souza Junior DA; Santana AC; da Silva EZ; Oliver C; Jamur MC
Biomed Res Int; 2015; 2015():142359. PubMed ID: 26146612
[TBL] [Abstract][Full Text] [Related]
7. Tryptase and chymase are angiogenic in vivo in the chorioallantoic membrane assay.
Ribatti D; Ranieri G; Nico B; Benagiano V; Crivellato E
Int J Dev Biol; 2011; 55(1):99-102. PubMed ID: 21425085
[TBL] [Abstract][Full Text] [Related]
8. Tryptase, a novel angiogenic factor stored in mast cell granules.
Ribatti D; Ranieri G
Exp Cell Res; 2015 Mar; 332(2):157-62. PubMed ID: 25478999
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic properties of calcium trifluoroacetate.
Bussolati B; Ribatti D; Munaron L; Bartorelli A; Bussolati G
Microvasc Res; 2009 Dec; 78(3):272-7. PubMed ID: 19631669
[TBL] [Abstract][Full Text] [Related]
10. The Hidden Side of Disodium Cromolyn: from Mast Cell Stabilizer to an Angiogenic Factor and Antitumor Agent.
Cimpean AM; Raica M
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(6):515-522. PubMed ID: 27289241
[TBL] [Abstract][Full Text] [Related]
11. The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor.
Friedli A; Fischer E; Novak-Hofer I; Cohrs S; Ballmer-Hofer K; Schubiger PA; Schibli R; Grünberg J
Int J Biochem Cell Biol; 2009 Jul; 41(7):1572-80. PubMed ID: 19401151
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic changes in co-cultures of mast cells and myocardial microvascular endothelial cells under hyperglycemic conditions.
Wang Z; Zhang Q; Zhu W; Tao J; Wei M
Int J Mol Med; 2013 May; 31(5):1177-85. PubMed ID: 23467570
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiogenic growth factor combinations on retinal endothelial cells.
Castellon R; Hamdi HK; Sacerio I; Aoki AM; Kenney MC; Ljubimov AV
Exp Eye Res; 2002 Apr; 74(4):523-35. PubMed ID: 12076096
[TBL] [Abstract][Full Text] [Related]
14. Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts.
Somasundaram P; Ren G; Nagar H; Kraemer D; Mendoza L; Michael LH; Caughey GH; Entman ML; Frangogiannis NG
J Pathol; 2005 Jan; 205(1):102-11. PubMed ID: 15586361
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiogenesis: a novel antitumor mechanism of the herbal compound arctigenin.
Gu Y; Scheuer C; Feng D; Menger MD; Laschke MW
Anticancer Drugs; 2013 Sep; 24(8):781-91. PubMed ID: 23744558
[TBL] [Abstract][Full Text] [Related]
16. Serum amyloid A stimulates cultured endothelial cells to migrate and proliferate: inhibition by the multikinase inhibitor BIBF1120.
Cai X; Freedman SB; Witting PK
Clin Exp Pharmacol Physiol; 2013 Sep; 40(9):662-70. PubMed ID: 23819722
[TBL] [Abstract][Full Text] [Related]
17. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic.
Ziche M; Maglione D; Ribatti D; Morbidelli L; Lago CT; Battisti M; Paoletti I; Barra A; Tucci M; Parise G; Vincenti V; Granger HJ; Viglietto G; Persico MG
Lab Invest; 1997 Apr; 76(4):517-31. PubMed ID: 9111514
[TBL] [Abstract][Full Text] [Related]
18. Evidence of human thrombomodulin domain as a novel angiogenic factor.
Shi CS; Shi GY; Chang YS; Han HS; Kuo CH; Liu C; Huang HC; Chang YJ; Chen PS; Wu HL
Circulation; 2005 Apr; 111(13):1627-36. PubMed ID: 15795324
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release.
van Mil A; Grundmann S; Goumans MJ; Lei Z; Oerlemans MI; Jaksani S; Doevendans PA; Sluijter JP
Cardiovasc Res; 2012 Mar; 93(4):655-65. PubMed ID: 22227154
[TBL] [Abstract][Full Text] [Related]
20. YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models.
Pan SL; Guh JH; Peng CY; Wang SW; Chang YL; Cheng FC; Chang JH; Kuo SC; Lee FY; Teng CM
J Pharmacol Exp Ther; 2005 Jul; 314(1):35-42. PubMed ID: 15784655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
